Cita APA (7a ed.)

Gettinger, S. N., Choi, J., Mani, N., Sanmamed, M. F., Datar, I., Sowell, R., . . . Schalper, K. A. (2018). A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers. Nature Portfolio.

Cita Chicago Style (17a ed.)

Gettinger, S. N., et al. A Dormant TIL Phenotype Defines Non-small Cell Lung Carcinomas Sensitive to Immune Checkpoint Blockers. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Gettinger, S. N., et al. A Dormant TIL Phenotype Defines Non-small Cell Lung Carcinomas Sensitive to Immune Checkpoint Blockers. Nature Portfolio, 2018.